🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Status
Completed
Location
Xijing Hospital
Start Date
2021-01-01
Trial ID
NCT07115095
Treatments Being Tested
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
The purpose of this study is to determine whether ETBX-021 is safe and effe...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2017-03-04
Trial ID
NCT02751528
Treatments Being Tested
This research study is studying an investigational drug as a possible treat...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2018-08-22
Trial ID
NCT03587740
Treatments Being Tested
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
POSNOC is a pragmatic, randomised, multicentre, non-inferiority trial. Aim...
Status
Active Not Recruiting
Location
Royal Adelaide Hospital
Start Date
2014-08-01
Trial ID
NCT02401685
Treatments Being Tested
Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2015-01-01
Trial ID
NCT06711055